Invention Grant
- Patent Title: Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
-
Application No.: US15637871Application Date: 2017-06-29
-
Publication No.: US10221461B2Publication Date: 2019-03-05
- Inventor: Harlan S. Robins , Julie Rubinstein , Ryan Emerson , Jianda Yuan
- Applicant: Adaptive Biotechnologies Corp. , Memorial Sloan-Kettering Cancer Center
- Applicant Address: US WA Seattle US NY New York
- Assignee: ADAPTIVE BIOTECHNOLOGIES CORP.,MEMORIAL SLOAN-KETTERING CANCER CENTER
- Current Assignee: ADAPTIVE BIOTECHNOLOGIES CORP.,MEMORIAL SLOAN-KETTERING CANCER CENTER
- Current Assignee Address: US WA Seattle US NY New York
- Agency: Cooley LLP
- Main IPC: C12Q1/6886
- IPC: C12Q1/6886 ; C12Q1/6851 ; C12Q1/6883 ; G06F19/22 ; G06F19/12

Abstract:
Disclosed are methods for determining the immunological status of the adaptive immune system of a subject by identifying and quantifying rearranged DNA (and/or subsequently transcribed RNA) sequences encoding T cell receptor (TCR) and/or immunoglobulin (IG) polypeptides, in a lymphoid DNA-containing sample from the subject TCR and/or IG sequence diversity and sequence distribution permit immunocompetence and immune repertoire assessment and reflect the degree of T cell or B cell clonality and clerical expansion in the sample. Methods for stratifying patient populations on the basis of immunocompetence including likelihood of responding to immunotherapy are also described.
Public/Granted literature
- US20180030543A1 IMMUNOCOMPETENCE ASSESSMENT BY ADAPTIVE IMMUNE RECEPTOR DIVERSITY AND CLONALITY CHARACTERIZATION Public/Granted day:2018-02-01
Information query
IPC分类: